U.S. Wireless Telecom Stock News

NYSE:CRS
NYSE:CRSAerospace & Defense

Does New Positive Coverage and CEO Transition Shift the Bull Case for Carpenter Technology (CRS)?

Earlier this week, Carpenter Technology Corporation participated in the JPMorgan Industrials Conference 2026 in Washington, D.C., while investors reacted to fresh analyst coverage and upcoming CEO transition plans. The combination of new brokerage research highlighting Carpenter Technology’s role in advanced aerospace and defense alloys and the planned handover from CEO Tony Thene to COO Brian Malloy has sharpened market attention on how leadership and industry positioning may shape the...
NasdaqCM:SSII
NasdaqCM:SSIIMedical Equipment

A Look At SS Innovations International (SSII) Valuation After Earnings And Auditor Going Concern Warning

SS Innovations International (SSII) drew investor attention after releasing its 2025 results, which combined higher reported revenue with a smaller annual net loss and, at the same time, a going concern warning from auditor BDO LLP. See our latest analysis for SS Innovations International. At a share price of US$5.01, SS Innovations International has seen a 25% 1 month share price return, while the year to date share price return and 1 year total shareholder return remain negative. This hints...
NasdaqGM:ALVO
NasdaqGM:ALVOBiotechs

Alvotech (ALVO) TTM Profitability Challenged By Q4 US$108.5 Million Net Loss

FY 2025 earnings snapshot for Alvotech (NasdaqGM:ALVO) Alvotech (NasdaqGM:ALVO) closed FY 2025 with Q4 revenue of US$168.9 million and a basic EPS loss of US$0.44, as net income excluding extra items came in at a loss of US$108.5 million. The company has seen quarterly revenue range from US$102.99 million in Q3 2024 to US$173.3 million in Q2 2025, while basic EPS has swung between a loss of US$0.23 in Q4 2024 and a profit of US$0.39 in Q1 2025. This sets up a year where the trailing twelve...
NasdaqGM:TATT
NasdaqGM:TATTAerospace & Defense

TAT Technologies (TATT) Margin Expansion To 9.4% Tests Bullish Efficiency Narrative

TAT Technologies (NasdaqGM:TATT) has wrapped up FY 2025 with fourth quarter revenue of US$46.5 million and basic EPS of US$0.36, capping a year in which trailing 12 month revenue reached US$178.0 million and EPS came in at US$1.39. Over recent periods the company has seen quarterly revenue move from US$41.0 million in Q4 2024 to US$46.5 million in Q4 2025. Basic EPS was US$0.36 a year ago and US$0.36 this quarter on a quarterly basis, and moved from US$1.08 to US$1.39 on a trailing 12 month...
NasdaqGM:ASST
NasdaqGM:ASSTMedical Equipment

Strive Asset Management (ASST) Q4 US$205.6m Loss Reinforces Bearish Earnings Narratives

Strive Asset Management (ASST) FY 2025 earnings snapshot Strive Asset Management (ASST) has just wrapped up FY 2025 with Q4 total revenue of about US$1.3 million and a loss per share of US$6.17, alongside a net loss excluding extra items of US$205.6 million, setting a stark backdrop for the latest numbers. Over the past year, revenue has moved from roughly US$0.8 million in Q2 2024 to US$1.3 million in Q4 2025, while trailing twelve month EPS shifted from a US$194.99 loss to a US$12.74 loss...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Is It Too Late To Consider Nebius Group (NBIS) After 364% One Year Surge?

If you are wondering whether Nebius Group's current share price reflects its true worth, the recent trading history gives you plenty to think about. The stock last closed at US$121.52, with returns of 12.5% over 7 days, 24.6% over 30 days, 35.1% year to date, and 364.3% over the past year. This will naturally raise questions about how much of the story is already priced in. Recent attention around Nebius Group has focused on its role in the software sector and how investors are treating high...
NYSE:TRC
NYSE:TRCReal Estate

Tejon Ranch (TRC) Q4 Profitability Rebound Challenges Bearish Earnings Narratives

Tejon Ranch (TRC) has just wrapped up FY 2025 with fourth quarter revenue of US$21.1 million and basic EPS of US$0.06, while the full year on a trailing 12 month basis came in at US$49.6 million of revenue and essentially breakeven EPS around US$0.00. Over recent quarters, the company has seen revenue move from US$8.3 million and basic EPS of a US$0.06 loss in Q2 2025 to US$11.0 million and a US$0.06 loss in Q3 2024, before reaching Q4 2025’s US$21.1 million and US$0.06 EPS. This sets up a...
NYSE:ACN
NYSE:ACNIT

Accenture (ACN) Margin Slip To 10.6% Tests Bullish Earnings Narratives

Accenture (ACN) has reported Q2 2026 results with revenue of US$18.0b and basic EPS of US$2.96, setting the tone for how its consulting and technology services engine is currently translating into top and bottom line performance. The company has seen quarterly revenue move from US$16.7b in Q2 2025 to US$18.0b in Q2 2026, while basic EPS over the same quarters has shifted from US$2.85 to US$2.96, giving investors a clear read on how sales and earnings are tracking together. With a trailing net...
NYSE:MOV
NYSE:MOVLuxury

Movado Group (MOV) Margin Improvement Tests Bullish Earnings Narratives

Movado Group (MOV) has wrapped up FY 2026 with fourth quarter revenue of US$191.6 million and basic EPS of US$0.55, supported by trailing twelve month revenue of US$671.3 million and EPS of US$1.17, alongside a 44.6% earnings increase over the past year. Over recent quarters, the company has seen revenue move from US$174.7 million and EPS of US$0.30 in Q4 FY 2025 to US$191.6 million and EPS of US$0.55 in Q4 FY 2026. At the same time, trailing net profit margin has shifted from 2.8% to 4%,...
NasdaqCM:SLNO
NasdaqCM:SLNOBiotechs

Soleno Lawsuit Puts DCCR Safety Disclosures And Growth Story Under Scrutiny

A class action lawsuit has been filed against Soleno Therapeutics (NasdaqCM:SLNO) alleging failures to disclose significant safety concerns in clinical trials for its drug DCCR. The complaint targets the company and certain executives, claiming that undisclosed issues could affect DCCR's commercial prospects and Soleno's reputation. The case focuses on the period around the development and launch preparations of DCCR, Soleno's sole commercial product. Soleno Therapeutics is a biotech...
NasdaqGS:AVAH
NasdaqGS:AVAHHealthcare

Aveanna Healthcare Holdings (AVAH) Return To Profitability Tests Bearish Earnings Narratives

Aveanna Healthcare Holdings (AVAH) delivers full year 2025 results Aveanna Healthcare Holdings (AVAH) has wrapped up FY 2025 with fourth quarter revenue of US$662.5 million, basic EPS of US$0.85 and net income excluding extraordinary items of US$178.8 million. This frames a year where trailing twelve month revenue reached about US$2.4 billion and basic EPS was US$1.11. Over recent periods the company has seen revenue move from US$519.9 million in Q4 FY 2024 to US$662.5 million in Q4 FY 2025,...
NYSE:YRD
NYSE:YRDConsumer Finance

Yiren Digital FY 2025 Margin Collapse Challenges High Quality Earnings Narrative

Yiren Digital’s FY 2025 Results Put Margins Under the Microscope Yiren Digital (NYSE:YRD) has just closed out FY 2025 with fourth quarter revenue of C¥957.6 million and a loss per share of C¥10.12, as net income excluding extra items came in at a loss of C¥882.2 million against a C¥2.03 share price. The company has seen quarterly revenue range from C¥1,652.1 million in Q2 2025 to C¥1,452.2 million in Q4 2024. Basic EPS moved from a profit of C¥3.84 in Q4 2024 to a loss in the latest quarter,...
NYSE:BFH
NYSE:BFHConsumer Finance

A Look At Bread Financial Holdings (BFH) Valuation After New Ford Partnership Announcement

Why the Ford partnership matters for Bread Financial Bread Financial Holdings (BFH) is back in focus after Ford Motor Company selected it for a long term co-branded credit card and installment loan program tied directly into Ford’s customer platforms. The market reaction has been constructive, with the stock recently up 3.1% alongside broader gains in financial names, as investors consider what this new Ford relationship could mean for Bread Financial’s card services and lending...
NYSE:NUVB
NYSE:NUVBPharmaceuticals

Is It Time To Reassess Nuvation Bio (NUVB) After Its Recent Share Price Swings?

If you are trying to work out whether Nuvation Bio is attractively priced or not, the recent share performance gives you some useful starting clues. At a last close of US$4.26, the stock has seen a 2.5% decline over the past week and a 27.6% decline over the past month, but is up 117.3% over 1 year and 156.6% over 3 years. Over 5 years, the return sits at a 59.4% decline. This mix of shorter term weakness and longer term strength has put valuation in sharper focus for many investors. With...
NasdaqGM:HYPR
NasdaqGM:HYPRMedical Equipment

Hyperfine (HYPR) Q4 Loss Improvement Tests Bullish Margin Narrative

Hyperfine (HYPR) closed out FY 2025 with Q4 revenue of US$5.3 million and a net loss of US$5.9 million, equal to a basic EPS loss of US$0.06. On a trailing twelve month basis it generated US$13.6 million of revenue and a total net loss of US$35.6 million, or a basic EPS loss of US$0.43. Over the past four reported quarters, revenue has moved from US$2.1 million in Q1 2025 to US$5.3 million in Q4 2025, while quarterly basic EPS losses ranged between US$0.06 and US$0.14 per share. This keeps...
NasdaqGS:CSIQ
NasdaqGS:CSIQSemiconductor

Canadian Solar (CSIQ) Is Down 25.0% After Posting 2025 Net Loss and Highlighting Storage Shift

Canadian Solar Inc. recently reported fourth-quarter 2025 results showing sales of US$1,217.21 million and a net loss of US$86.34 million, with the full year turning from profit to a net loss of US$104.13 million on lower sales of US$5,595.11 million. Alongside these weaker earnings, the company highlighted growing momentum in its energy storage business, including a sizeable U.S. battery project win and increased storage shipments, underscoring a shift in where future growth may come...
NasdaqGS:LX
NasdaqGS:LXConsumer Finance

LexinFintech Holdings (NasdaqGS:LX) Margin Expansion Challenges Cautious Growth Narratives

LexinFintech Holdings (NasdaqGS:LX) FY 2025 earnings snapshot LexinFintech Holdings (NasdaqGS:LX) has wrapped up FY 2025 with fourth quarter revenue of C¥3,043.1 million and basic EPS of C¥1.27, capping a year where trailing twelve month revenue came in at C¥13.2 billion and EPS reached C¥9.90. Over the past few quarters the company has seen revenue move from C¥3,587.4 million in Q2 2025 to C¥3,417.5 million in Q3 2025 and then C¥3,043.1 million in Q4 2025, while quarterly EPS shifted from...
NasdaqCM:OSS
NasdaqCM:OSSTech

One Stop Systems (OSS) Swings To Q3 Profit Challenging Longstanding Loss Narrative

One Stop Systems (OSS) has put up a mixed FY 2025 scorecard so far, with Q3 revenue of about US$18.8 million and basic EPS of roughly US$0.01, alongside trailing 12 month revenue of about US$60.3 million and a loss of roughly US$6.9 million on a basic EPS basis of about US$0.32. The company has seen quarterly revenue move from about US$13.2 million in Q2 2024 to US$15.1 million in Q4 2024, then to US$12.3 million in Q1 2025, US$14.1 million in Q2 2025 and US$18.8 million in Q3 2025. Basic EPS...
NYSE:HGV
NYSE:HGVHospitality

How Kyoto Resort Opening and Sustainability Push Will Impact Hilton Grand Vacations (HGV) Investors

Hilton Grand Vacations has opened Tradimo Kyoto Gojo, its first property in Kyoto and third in Japan, offering 63 one-bedroom suites near Kyoto Station and key cultural districts. The company is pairing this physical expansion with a partnership with the Kyoto Tourism Board and local nonprofits to support sustainable tourism and community initiatives in the region. We’ll now explore how this Kyoto opening, and HGV’s broader expansion in Japan, could influence the company’s investment...
NYSE:NSA
NYSE:NSASpecialized REITs

Is It Time To Reassess National Storage Affiliates (NSA) After Its Recent Share Price Surge

Many investors may be wondering if National Storage Affiliates Trust is priced fairly or offering value right now, especially after its recent run in the market. The stock last closed at US$38.84, with returns of 25.5% over 7 days, 14.0% over 30 days, 39.3% year to date, 8.8% over 1 year, 21.2% over 3 years and 28.3% over 5 years, figures that many investors will want to put into context. Recent coverage has focused on how National Storage Affiliates Trust fits into the broader self storage...
NasdaqGS:STGW
NasdaqGS:STGWMedia

Is Stagwell (STGW) Now Attractive After A 31% Monthly Share Price Jump?

Wondering if Stagwell at around US$6.21 is offering value or just noise in your portfolio? This article breaks down what that price could really mean for you. Over the last month the share price is up 31.0%, after a 1.0% decline over the past week, with a 31.3% return year to date and 1.8% over the past year setting the recent context. Recent coverage around Stagwell has focused on its position within the media sector and how investors are weighing its execution against peers. This backdrop...
NasdaqCM:SATL
NasdaqCM:SATLAerospace & Defense

Satellogic (SATL) Q4 Profitability Sparks Debate Over Rich 26.5x Sales Multiple

Satellogic (NasdaqCM:SATL) closed out FY 2025 with Q4 revenue of US$6.2 million and basic EPS of US$0.23, alongside trailing twelve month revenue of US$17.7 million and a trailing EPS loss of US$0.04. Over recent quarters the company has seen revenue move from US$3.4 million in Q1 2025 to US$6.2 million in Q4 2025, while quarterly EPS ranged from a loss of US$0.34 in Q1 2025 to a profit of US$0.23 in Q4 2025. This sets up a results season where investors are likely to focus on how durable any...
NYSE:UPS
NYSE:UPSLogistics

UPS Tire Standardization With Equal Flexxx Puts Focus On Efficiency And Valuation

United Parcel Service (NYSE:UPS) has approved EQUAL FLEXX for its 2026 Tire Solutions Program after a nationwide multi year field evaluation. This is the first time EQUAL FLEXX will be used as a standard tire solution across UPS’s extensive fleet. The move is part of UPS’s efforts to sharpen safety, reliability, and cost control in its operations. UPS is putting a concrete operational change in focus at a time when its share price, at $96.56, reflects mixed sentiment, with a 30 day return...